Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening in gynecologic cancers

H E Averette1, A Steren, H N Nguyen

  • 1Department of Obstetrics & Gynecology, University of Miami School of Medicine, FL 33101.

Cancer
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seroprevalence of Toxocara at Tra Vinh University Hospital in Vietnam.

European review for medical and pharmacological sciences·2023
Same author

Influence of Irradiation on the Biology of the Brown Marmorated Stink Bug (Hemiptera: Pentatomidae).

Journal of economic entomology·2021
Same author

Using online tools at the Bovine Genome Database to manually annotate genes in the new reference genome.

Animal genetics·2020
Same author

Adapting a TB contact investigation strategy for COVID-19.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Abdominal Morcellation After Laparoscopic Removal of Large Pelvic Masses: A New Technique.

Journal of minimally invasive gynecology·2016
Same author

Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.

Oncogene·2013
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Early detection is key for improving survival in gynecologic cancers, as treatments have seen limited advancement. Patient education and regular screenings, including the Papanicolaou (Pap) test, are crucial for identifying at-risk individuals and optimizing outcomes.

Area of Science:

  • Gynecology
  • Oncology
  • Preventive Medicine

Background:

  • Gynecologic malignancies represent 13% of cancers in women, with ovarian and uterine cancers being leading causes of cancer death.
  • Improved survival rates are primarily due to early diagnosis rather than advancements in treatment.
  • Despite available screening and treatments, incidence rates remain unacceptably high.

Purpose of the Study:

  • To emphasize the critical role of early diagnosis in improving survival for gynecologic cancers.
  • To highlight the importance of provider knowledge and patient responsibility in cancer screening and risk identification.
  • To review current and emerging screening techniques for gynecologic malignancies.

Main Methods:

  • Review of current screening practices, including Papanicolaou (Pap) tests and regular gynecologic examinations.

Related Experiment Videos

  • Discussion of emerging diagnostic tools such as Human Papillomavirus (HPV) DNA typing, cervicography, and transvaginal ultrasonography.
  • Exploration of serum CA 125 measurements and endometrial sampling as potential screening modalities.

    • Main Results:

    • The Papanicolaou (Pap) test is a universally accepted screening procedure for cervical cancer.
    • Newer techniques like HPV DNA typing and transvaginal ultrasonography show promise as future screening tools.
    • Prospective studies are needed to fully establish the value of these novel modalities.

    Conclusions:

    • Early diagnosis remains the most significant factor in improving survival for gynecologic cancers.
    • Patient education and adherence to regular screenings are paramount for early detection.
    • Emerging technologies are expected to provide valuable prognostic information and influence future clinical care.